The 16th International Conference on Alzheimer`s Drug Discovery 2015 is dedicated to the development of innovative treatments for Alzheimer’s disease and related dementias.
The 16th International Conference on Alzheimer`s Drug Discovery 2015 covers topics such as:
- Prevention of Glial Neuroinflammation in Alzheimer`s Disease—Targeting a Novel Receptor to Preserve Neurocognitive Function
- EP2 Antagonists for the Suppression of Inflammation and Neuropathology
- Fingolimod Therapy in Models of Alzheimer’s Disease
- Optimization of P2X7 Antagonists for AD Treatment
- A Novel Fmri Biomarker of Asymptomatic Alzheimer`s Disease
- Development of Klotho Enhancers as Novel Therapeutics for Alzheimer’s Disease
- Benfotiamine in Alzheimer`s Disease: A Pilot Study
The 16th International Conference on Alzheimer`s Drug Discovery 2015 brings together:
- Academic and industry scientists involved in drug discovery research for neurodegenerative diseases and CNS
- Business development and licensing professionals
- Venture capitalists and other investors
- Alliance management professionals
